Magazine Article
| August 9, 2017

Sanat Chattopadhyay — Shaping Merck's Manufacturing Future

Sanat Chattopadhyay knows what it is like to face difficult tasks in the biopharma industry. When he was just 30 years old he was tapped to be the CEO of a small, wholly owned subsidiary of Hoechst Pharmaceuticals, India, engaged in manufacturing and selling of semisynthetic beta lactum antibiotics. The company wasn’t doing well, but he was expected to create something that he would be asked for over and over during his future career — a transformational turnaround.